Effect of BMI1 Knockdown on Cell Proliferation, Apoptosis, Invasiveness, and Migration of U251 Glioma Cells

키워드

참고문헌 (41)

1. Wong ML., "Targeting malignant glioma survival signalling to improve clinical outcomes", J Clin Neurosci, 14, pp.301~308 (2007)
2. Li DW., "Expression level of Bmi-1 oncoprotein is associatedwith progression and prognosis in colon cancer", J Cancer ResClin Oncol, 136, pp.9971006~ (2010)
3. Van Meir EG., "Exciting new advances in neurooncology : the avenue to a cure for malignantglioma", CA Cancer J Clin, 60, pp.166~193 (2010)
4. Jie M, "May Human U87 astrocytoma cell invasion iInduced by interaction of big-h3 with integrin a5b1 involves Calpain-2", Plos One, 7(5), pp.e37297~ (2012)
5. Townson JL., "Dormancy of solitary metastaticcells", Cell Cycle, 5, pp.1744~1750 (2006)
6. Mikheeva SA., "TWIST1 promotes invasion through mesenchymal change in human glioblastoma", Mol Cancer, 9, pp.194~ (2010)
7. ValkLingbeek ME., "Stem cells and cancer : the polycomb connection", Cell, 118, pp.409~418 (2004)
8. Widschwendter M., "Epigenetic stem cell signature in cancer", Nat. Genet, 39, pp.157~158 (2007)
9. Du J., "Polycomb group protein BMI1expression in colin cancers predicts the survival", Med Oncol, 27, pp.1273~1276 (2010)
10. Kim J., "The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a", p14ARF proteins, 2004, pp.203, 217~224
11. Nowak K., "BMI-1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas", NucleicAcids Res, 34, pp.1745~1754 (2006)
12. Song LB., "Bmi-1 is a novel molecular markerof nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells", Cancer Res, 66, pp.6225~6232 (2006)
13. Rich JN., "Development of novel targeted therapies in the treatment of malignant glioma", Nat Rev Drug Discov, 3, pp.430~446 (2004)
14. Nakamizo A., "Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas", Cancer Res, 15, pp.3307~3318 (2005)
15. Abdouh M., "BMI1 sustains human glioblastoma multiforme stem cell renewal", J Neurosci, 29(28), pp.8884~8894 (2009)
16. Hoenerhoff MJ., "BMI1 Cooperates with H-RAS to induce an aggressive breast cncer phenotype with brain metastases", Oncogene, 12(23), pp.6960~6966 (2009)
17. Song HF., "Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma", J Cancer Res Clin Oncol, 134, pp.535~541 (2008)
18. Eugenia A., "The Role of BMI1as a Biomarker of Cancer Stem Cells in Head and Neck Cancer : A Review", Oncology, 86, pp.199~205 (2014)
19. Jing WU., "Depletion of Bmi-1enhances 5-fluorouracil-induced apoptosis and autophagy in hepatocellular carcinoma cells", Oncology Letters, 4, pp.723~726 (2012)
20. Liang J, "Bmi-1 regulates the migration and invasion of glioma cells through p16", Cell biology international, 39(3), pp.283~290 (2015)[DOI]
21. Ye L., "Bmi-1induces radioresistance by suppressing senescence in human U87 glioma cells", Oncology letters, 8(6), pp.2601~2606 (2014)[DOI]
22. Jiang L., "Bmi-1 promotes glioma angiogenesis by activating NF-kappaB signaling", PloS one, 8(1), pp.e55527~ (2013)[DOI]
23. Mason EF., "Cell metabolism : an essential linkbetween cell growth and apoptosis", Biochim Biophys Acta, 1813, pp.645~654 (2011)
24. DeBerardinis RJ., "Thebiology of cancer : metabolic reprogramming fuels cell growth and proliferation", Cell Metab, 7, pp.11~20 (2008)
25. Saelens X., "Toxic proteins released from mitochondria in cell death", Oncogene, 23, pp.2861~2874 (2004)
26. Deng Y, . Ren X., "A JNK-dependent pathway is required for TNFalpha-induced apoptosis", Cell, 115, pp.61~70 (2003)
27. Ola MS., "Role of Bcl-2 family proteins and caspases in the regulation of apoptosis", Mol Cell Biochem, 351, pp.41~58 (2011)
28. Pastorino JG, "The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition", The Journal of biological chemistry, 273(13), pp.7770~7775 (1998)
29. Deng Y., "TRAIL-induced apoptosis requires Bax dependent mitochondrial release of Smac", DIABLO, 2002, pp.16, 33~45
30. Chauhan D, "Apaf-1", cytochrome c-independent and Smac dependent induction of apoptosis in multiple myeloma (MM)cell, 2001, 24453~24456
31. Schimmer AD., "Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity", Cancer Cell, 5, pp.25~35 (2004)
32. Baba Y., "Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers", Cancer, 117, pp.1399~1408 (2011)
33. McNamara CR., "Small-molecule inhibitors of the PI3K signaling network", Future Med Chem, 3, pp.549~565 (2011)
34. Song G., "The activation of Akt", PKB signaling pathway and cell survival, 2005, pp.9, 59~71
35. Vivanco I, "The phosphatidylinositol 3-kinase AKT pathway in human cancer", Nat Rev Cancer, 2, pp.489~501 (2002)
36. Kops GJ, "Forkhead transcription factors are targets of signalling by the proto-oncogene PKB(C-AKT)", J Anat, 197(4), pp.571~574 (2000)
37. Lau CJ., "Differential response of glioma cells to FOXO1-directed therapy", Cancer Res, 69, pp.5433~5440 (2009)
38. Greer EL., "FOXO transcription factors at the interface between longevity and tumor suppression", Oncogene, 24, pp.7410~7425 (2005)
39. Li X., "Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2, MMP-9 and vascular endothelial growth factor via the PTEN", PI3K, International journal of oncology, pp.2013, 43(3)[DOI]
40. Zheng H, "Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma", Anticancer research, 26(5a), pp.3579~3583 (2006)
41. Qiu S, "A computational study of offtarget effects of RNA interference", Nucleic acids research, 33(6), pp.1834~1847 (2005)[DOI]

관련 논문AI추천